Arsenale Bioyards

Investment Climate Podcast Arsenale Bioyards

© Investment Climate Podcast
Investments & Finance

Investment Climate Podcast: Massimo Portincaso of Arsenale BioYards, How to Get Funded in 2025

In this podcast series, Alex Shandrovsky interviews investors about benchmarks for funding Alt Proteins in 2025 and uncovers the investment playbooks of successful Climate Tech CEOs and Leading VCs. Podcast Host Alex Shandrovksy is a strategic advisor to numerous global food tech accelerators and companies, including alternative proteins and cellular agriculture leaders. His focus is on investor relations and post-raise scale for agrifood tech companies. This podcast is syndicated through our media partners; Foodtech Weekly and Vegconomist. Episode 26: Arsenale BioYards In this episode, I sat down with Massimo Portincaso, CEO and co-founder of Arsenale BioYards, who just raised a €10M seed round to tackle one of biotech’s toughest challenges: making biomanufacturing economically viable at scale. Massimo breaks down how his team is redesigning the …

more

Arsenale Bioyards

© Arsenale Bioyards
Fermentation

Investors Back Arsenale Bioyards with $10M to Scale AI-Driven Precision Fermentation

Arsenale Bioyards has raised $10 million in seed financing to support its efforts in reducing biomanufacturing costs and accelerating industrial-scale adoption of bio-based alternatives. The funding round was led by Planet A and byFounders, with additional participation from CDP Ventures, Acequia Capital, Plug and Play, Gray Silo Ventures, and several industrial family offices. The company focuses on optimizing precision fermentation, a process that utilizes microorganisms such as yeast or bacteria to produce proteins and other compounds. While this technology has been widely applied in pharmaceuticals, its expansion into food and cosmetics has been constrained by high production costs. Arsenale’s end-to-end biomanufacturing platform integrates industrial-scale bioreactors with AI-driven software to reduce costs and time-to-market, with the company projecting cost reductions of up to 90%. Scaling from …

more